Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit
FASCO 2027: Recognizing Dedication to Oncology
ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results
A New Chance to Prevent Recurrence: EU Approves Trastuzumab Deruxtecan for HER2-Positive Early Breast Cancer
Jeff Dunn on Cancer Equity: The Powerful Message Behind “Poverty Is a Carcinogen”
Top Gastroesophageal Cancer Updates From ESMO 2026
Carla Ferrell and Sista Strut 2026: Breast Cancer Awareness Mission
Arun Azad: New TALAPRO-2 Data Highlight the Prognostic Value of ctDNA and CTCs in Prostate Cancer
The World Radiotherapy Awareness Day (WRAD) 2026 will be observed globally on 7 September 2026, bringing together the international radiotherapy community under the theme “One Voice for Radiotherapy.” Coordinated by the World Radiotherapy Awareness Day initiative, led by co-chairs Sandra Turner and Katie Wakeham, the campaign aims to raise awareness of radiotherapy as an essential […]
World Cancer Day is observed annually on February 4 to raise awareness about cancer, promote its prevention, and inspire global action to tackle the growing cancer crisis. The day is coordinated by the Union for International Cancer Control (UICC). The Origins of World Cancer Day World Cancer Day was established on 4 February 2000 during […]
January 23rd of 2025 marks the International BPDCN Day. We unite to shed light on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare and aggressive hematologic malignancy that often remains underdiagnosed due to its rarity and complex presentation. What do we know about BPDCN? In 2008, BPDCN was recognized by the WHO as a distinct […]
